Avatar for GraftWorx

Fixing dialysis care

Fixing dialysis care

GraftWorx has developed a noninvasive remote monitoring solution for fluid management in hemodialysis patients. Our solution will generate $8 billion of value by growing revenue for dialysis providers and creating cost savings for payers. The GraftWorx system has been validated on 115 patients across 3 clinical studies and we expect to receive FDA clearance in late 2019. We have closed a strategic partnership with WL Gore and a clinical partnership with a prospective dialysis customer who manages ~6,000 patients.
Founder, GraftWorx. Founded O2 Insights (Sold to Systagenix). Also a PhD in Biomedical Engineering

David Kuraguntla

Avatar for David Kuraguntla
Founder and CEO of @GraftWorx • Attended medical school and Research at @National Institutes of Health • Studied at @Grove City College
Total raised

$2.9M

Funded over

1 round

Latest round

Seed (Jun 2016)

GraftWorx hasn't added any jobs yet

Get notified when GraftWorx posts new jobs.

See similar jobs